Barbarino A, De Marinis L, Lafuenti G, Muscatello P, Matteucci B
J Endocrinol Invest. 1979 Jan-Mar;2(1):41-4. doi: 10.1007/BF03349273.
Three adult patients with male pseudohermaphroditism were given 15 microgram/kg body weight of 17 beta-estradiol im daily (at 08:00 hours) for 12-15 days and circulating levels of gonadotropins, prolactin and estradiol were determined by radioimmunoassay before and during the steriod course. All patients had elevated gonadotropin levels prior to starting on estradiol. During estrogen treatment all patients demonstrated suppression of FSH and LH with a subsequent rise in LH (positive feedback) while estrogen levels remained elevated. A similar positive feedback effect on the secretion of FSH could not be demonstrated. In two patients, who had never received estrogen treatment prior to this study, estradiol induced a significant elevation of serum prolactin levels within 24 h and levels remained higher than basal values for the rest of the estrogen treatment period. In the third patient, who had been previously treated with estrogen, serum prolactin levels did not change significantly during estrogen treatment. This study was afforded evidence for the presence in humans of an estrogen mediated LH release concomitant with an augmented prolactin secretion.
三名成年男性假两性畸形患者每天上午8点肌肉注射15微克/千克体重的17β-雌二醇,共注射12 - 15天。在使用类固醇治疗前及治疗期间,通过放射免疫分析法测定促性腺激素、催乳素和雌二醇的循环水平。所有患者在开始使用雌二醇前促性腺激素水平均升高。在雌激素治疗期间,所有患者的促卵泡生成素(FSH)和促黄体生成素(LH)均受到抑制,随后LH升高(正反馈),而雌激素水平仍保持升高。未观察到对FSH分泌有类似的正反馈作用。在本研究之前从未接受过雌激素治疗的两名患者中,雌二醇在24小时内使血清催乳素水平显著升高,在雌激素治疗的剩余时间内该水平一直高于基础值。在第三名此前接受过雌激素治疗的患者中,雌激素治疗期间血清催乳素水平无显著变化。本研究为人体中存在雌激素介导的LH释放并伴有催乳素分泌增加提供了证据。